Dubravka Drabek

This inventor holds 10 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Erasmus University Medical Centre, Erasmus University Medical Center, Harbour Biomed (Shanghai) Co., Ltd.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dubravka Drabek. Retrieved from https://idiyas.com/inventor/dubravka-drabek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 92(Granted Patents)

Company Filing History:

5 out of 5

Erasmus University Medical Centre

patents

2 out of 80

Erasmus University Medical Center

patents

2 out of 3

Harbour Biomed (Shanghai) Co., Ltd.

patents

4. 1 out of 1

Harbour Antibodies Bv

patent

Years Active: 2014-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12599668 - ANTIBODIES (2026-04-14),

2. 12240905 - Antibodies binding CTLA-4 and uses thereof (2025-03-04),

3. 11098122 - Antibodies binding CTLA-4 and uses thereof (2021-08-24),

4. 10906970 - Methods of making heavy chain only antibodies using transgenic animals (2021-02-02),

5. 9365655 - Soluble heavy-chain only antibodies (2016-06-14),

6. 9353179 - Binding molecules (2016-05-31),

7. 9346877 - Binding molecules (2016-05-24),

8. 8921524 - Binding molecules (2014-12-30),

9. 8921522 - Binding molecules (2014-12-30),

10. 8883150 - Soluble 'heavy-chain only' antibodies (2014-11-11),

Title: The Innovative Contributions of Dubravka Drabek

Introduction

Dubravka Drabek is a prominent inventor based in Rotterdam, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of nine patents to her name, Drabek's work has the potential to impact the treatment of various diseases, including cancers and autoimmune disorders.

Latest Patents

Among her latest patents is the invention of antibodies binding to CTLA-4. These isolated monoclonal antibodies comprise a CD152-binding domain, specifically targeting human CD152. The methods of making and using these antibodies are designed to treat diseases, including cancers and autoimmune diseases. This innovative approach showcases her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Drabek has had a distinguished career, working at esteemed institutions such as Erasmus University Medical Centre. Her research and inventions have garnered attention in the scientific community, highlighting her expertise and dedication to her field.

Collaborations

Throughout her career, Drabek has collaborated with notable colleagues, including Roger Kingdon Craig and Franklin Gerardus Grosveld. These partnerships have further enriched her research and contributed to her success as an inventor.

Conclusion

Dubravka Drabek's innovative work in the field of biotechnology, particularly her patents related to monoclonal antibodies, underscores her significant contributions to medical science. Her dedication to advancing treatment options for serious diseases is commendable and reflects her status as a leading inventor in her field.

Profile summary based on public USPTO records.